Ming Ming Wen
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 10%
- Electrospun Nanofibers in Biomedical Applications
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advancements in Transdermal Drug Delivery 5
- Advanced Drug Delivery Systems 4
-
- RNA Interference and Gene Delivery 3
- Co-authors
- Amal H. El‐Kamel (4 shared papers)Ragwa M. Farid (3 shared papers)Amira Sayed Hanafy (2 shared papers)Nashiru Billa (1 shared paper)Noha S. El-Salamouni (1 shared paper)Wessam M. El-Refaie (1 shared paper)Giovanni Tosi (1 shared paper)María J. Blanco‐Prieto (1 shared paper)
- Journals
- Drug Delivery (2 papers)Pharmaceutics (1 paper)Current Drug Delivery (1 paper)Pharmacy Practice (1 paper)Journal of Liposome Research (1 paper)
- Partner nations
- EgyptUnited StatesSaudi Arabia
In The Last Decade
Ming Ming Wen
18 papers receiving 546 citations
Peers
Comparison fields: 5 of 88
- Pharmaceutical Science 170
- Biomaterials 119
- Molecular Medicine 29
- Rehabilitation 21
- Developmental Neuroscience 12
Countries citing papers authored by Ming Ming Wen
This map shows the geographic impact of Ming Ming Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Ming Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Ming Wen more than expected).
Fields of papers citing papers by Ming Ming Wen
This network shows the impact of papers produced by Ming Ming Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Ming Wen. The network helps show where Ming Ming Wen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Ming Wen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 159 | |
| 2 | 2017 | 88 | |
| 3 | 2016 | 74 | |
| 4 | 2014 | 46 | |
| 5 | 2021 | 39 | |
| 6 | Olfactory targeting through intranasal delivery of biopharmaceutical drugs to the brain: current development. | 2011 | 38 |
| 7 | 2021 | 26 | |
| 8 | 2014 | 19 | |
| 9 | 2011 | 18 | |
| 10 | 2020 | 15 | |
| 11 | 2016 | 14 | |
| 12 | 2024 | 8 | |
| 13 | 2024 | 5 | |
| 14 | 2025 | 2 | |
| 15 | Advances and challenges in the dosage form design for the treatment of Parkinson's disease. | 2012 | 2 |
| 16 | 2016 | 1 | |
| 17 | [Magnetic Resonance Imaging Tracing the Biodistribution of SPIO-shRNA Molecular Probe in vivo]. | 2016 | 1 |
| 18 | 2025 | 1 |
About Ming Ming Wen
Ming Ming Wen is a scholar working on Pharmaceutical Science, Molecular Biology, Dermatology, Rehabilitation and Food Science, having authored 18 papers that have together received 556 indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (5 papers), Advanced Drug Delivery Systems (4 papers), RNA Interference and Gene Delivery (3 papers), Wound Healing and Treatments (2 papers), Dermatology and Skin Diseases (2 papers), MicroRNA in disease regulation (2 papers), Essential Oils and Antimicrobial Activity (2 papers) and Pharmaceutical Practices and Patient Outcomes (1 paper). The work is most often cited by research in Pharmaceutical Science (170 citations), Biomaterials (119 citations), Molecular Medicine (29 citations), Rehabilitation (21 citations) and Developmental Neuroscience (12 citations). Ming Ming Wen has collaborated with scholars based in Egypt, United States and Saudi Arabia. Frequent co-authors include Amal H. El‐Kamel, Ragwa M. Farid, Amira Sayed Hanafy, Nashiru Billa, Noha S. El-Salamouni, Wessam M. El-Refaie, Giovanni Tosi, María J. Blanco‐Prieto, Heba A. Hazzah and Mai M. Ali. Their work appears in journals such as Drug Delivery, Pharmaceutics, Current Drug Delivery, Pharmacy Practice and Journal of Liposome Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.